Bushnell, C., Alberts, M., Frankel, M., Goldstein, L. B., Gorelick, P., Johnston, S. C., … Peterson, E. (2008). Adherence eValuation after ischemic stroke longitudinal (AVAIL): Identifying facilitators of adherence to stroke prevention medications. In STROKE (Vol. 39, pp. 556–556). New Orleans, LA: LIPPINCOTT WILLIAMS & WILKINS.

Bushnell, Cheryl, Mark Alberts, Michael Frankel, Larry B. Goldstein, Philip Gorelick, S Claiborne Johnston, Chelsea Kidwell, Lee Schwamm, Linda Williams, and Eric Peterson. “Adherence eValuation after ischemic stroke longitudinal (AVAIL): Identifying facilitators of adherence to stroke prevention medications.” In STROKE, 39:556–556. LIPPINCOTT WILLIAMS & WILKINS, 2008.

Bushnell C, Alberts M, Frankel M, Goldstein LB, Gorelick P, Johnston SC, et al. Adherence eValuation after ischemic stroke longitudinal (AVAIL): Identifying facilitators of adherence to stroke prevention medications. In: STROKE. LIPPINCOTT WILLIAMS & WILKINS; 2008. p. 556–556.

Bushnell, Cheryl, et al. “Adherence eValuation after ischemic stroke longitudinal (AVAIL): Identifying facilitators of adherence to stroke prevention medications.” STROKE, vol. 39, no. 2, LIPPINCOTT WILLIAMS & WILKINS, 2008, pp. 556–556.

Bushnell C, Alberts M, Frankel M, Goldstein LB, Gorelick P, Johnston SC, Kidwell C, Schwamm L, Williams L, Peterson E. Adherence eValuation after ischemic stroke longitudinal (AVAIL): Identifying facilitators of adherence to stroke prevention medications. STROKE. LIPPINCOTT WILLIAMS & WILKINS; 2008. p. 556–556.